Literature DB >> 23356853

Effect of protamine on the accumulation of gentamicin in opossum kidney epithelial cells.

Junya Nagai1, Takuji Komeda, Ryoko Yumoto, Mikihisa Takano.   

Abstract

OBJECTIVES: The purpose of this study was to examine whether or not protamine, an arginine-rich basic protein mixture, inhibits the accumulation of gentamicin, a nephrotoxic drug, in cultured opossum kidney (OK) epithelial cells.
METHODS: The effect of protamine from salmon on accumulation and binding of [(3) H]gentamicin was investigated in OK cells. KEY
FINDINGS: Protamine inhibited the binding and accumulation of [(3) H]gentamicin in a concentration-dependent manner. The accumulation of [(14) C]inulin, a marker of fluid-phase endocytosis, was not affected by protamine at concentrations up to 1 mm. l-Arginine at concentrations up to 10 mm had no significant effect on the accumulation of [(3) H]gentamicin. On the other hand, preincubation with 100 μm protamine for 5 min decreased the accumulation of [(3) H]gentamicin to almost the same extent as coincubation with 100 μm protamine for 60 min.
CONCLUSIONS: Our results indicate that protamine decreases the accumulation of gentamicin in OK cells. These findings suggest that protamine or its derivatives might be useful in preventing the nephrotoxicity of aminoglycoside antibiotics including gentamicin.
© 2012 The Authors. JPP © 2012. Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23356853     DOI: 10.1111/jphp.12005

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Sodium-glucose transporter-2 (SGLT2; SLC5A2) enhances cellular uptake of aminoglycosides.

Authors:  Meiyan Jiang; Qi Wang; Takatoshi Karasawa; Ja-Won Koo; Hongzhe Li; Peter S Steyger
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

2.  Protective effect of L-arginine on gentamicin-induced nephrotoxicity in rats.

Authors:  İbrahim Başhan; Perihan Başhan; Mehmet Ata Seçilmiş; Ergin Şingirik
Journal:  Indian J Pharmacol       Date:  2014 Nov-Dec       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.